Xenetic Biosciences, Inc. (XBIO): Price and Financial Metrics
XBIO Price/Volume Stats
| Current price | $2.96 | 52-week high | $5.20 |
| Prev. close | $3.10 | 52-week low | $2.20 |
| Day low | $2.91 | Volume | 1,600 |
| Day high | $3.18 | Avg. volume | 7,365 |
| 50-day MA | $2.82 | Dividend yield | N/A |
| 200-day MA | $3.70 | Market Cap | 4.56M |
XBIO Stock Price Chart Interactive Chart >
Xenetic Biosciences, Inc. (XBIO) Company Bio
Xenetic Biosciences, Inc. operates as a biopharmaceutical company. The Company focuses on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens, as well as offers cell-based therapeutics targeting the B-cell receptor on the surface of malignant tumor cells. Xenetic Biosciences serves patients in the United States.
XBIO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
XBIO Price Returns
| 1-mo | -6.00% |
| 3-mo | -21.38% |
| 6-mo | -31.64% |
| 1-year | -24.30% |
| 3-year | -59.33% |
| 5-year | -72.08% |
| YTD | -25.81% |
| 2024 | 15.65% |
| 2023 | 21.01% |
| 2022 | -77.90% |
| 2021 | -36.76% |
| 2020 | 41.67% |